Trevi Therapeutics (TRVI) Operating Leases (2018 - 2026)
Trevi Therapeutics' Operating Leases was $276,000 in Q2 2026, down 54.4% from $605,000 a year earlier and down 24.2% from the prior quarter.
Powered by 
Analysis
Trevi Therapeutics (TRVI) Operating Leases (2018 - 2026) Analysis & Trends
At the end of FY2025, Operating Leases at Trevi Therapeutics came in at $446,000, down 40.3% from FY2024.
- Operating Leases shows a five-year compound annual growth rate of 25.4% (FY2020 to FY2025).
- In earlier years, Operating Leases was $747,000 in FY2024 (-25.4%), $1 million in FY2023, $2,000 in FY2022 (-91.7%) and $24,000 in FY2021 (-83.3%).
- The Q2 2026 figure marks the lowest quarterly Operating Leases since Q4 2022.
- Compared with a year earlier, Operating Leases has declined for ten straight quarters, with an average decline of 35.5% over the last eight quarters.
- The year-over-year decline in Operating Leases has ranged between 17.3% (Q1 2024) and 96.7% (Q2 2022) over the last five years.
- Per Business Quant data, TRVI's Operating Leases in the three quarters before Q2 2026 was $364,000 (Q1 2026), $446,000 (Q4 2025) and $527,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Trevi Therapeutics | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 276,000.00 |
| Mar 31, 2026 | 364,000.00 |
| Dec 31, 2025 | 446,000.00 |
| Sep 30, 2025 | 527,000.00 |
| Jun 30, 2025 | 605,000.00 |
| Mar 31, 2025 | 681,000.00 |
| Dec 31, 2024 | 747,000.00 |
| Sep 30, 2024 | 816,000.00 |
| Jun 30, 2024 | 884,000.00 |
| Mar 31, 2024 | 949,000.00 |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Dec 31, 2021 | 24,000.00 |
| Sep 30, 2021 | 58,000.00 |
| Jun 30, 2021 | 91,000.00 |
API Access
Trevi Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=TRVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "TRVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=TRVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();